Cargando…
Disparities in patient enrollment on glioblastoma clinical trials
AIM: To determine if enrollment on glioblastoma (GBM) interventional clinical trials (ICTs) in the USA is representative of the population. MATERIALS & METHODS: We queried ClinicalTrials.gov for all ICTs in GBM from 1994 to 2019. Demographics were obtained from ClinicalTrials.gov or the trial pu...
Autores principales: | Liu, Yang, Wasilewski, Andrea, Mohile, Nimish A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Medicine Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7341158/ https://www.ncbi.nlm.nih.gov/pubmed/32603616 http://dx.doi.org/10.2217/cns-2020-0008 |
Ejemplares similares
-
Durable response to bevacizumab in adults with recurrent pilocytic astrocytoma
por: Wasilewski, Andrea, et al.
Publicado: (2018) -
Tele-neuro-oncology: Current Practices and Future Directions
por: Wasilewski, Andrea, et al.
Publicado: (2022) -
Health selection into neighborhoods among patients enrolled in a clinical trial
por: Arcaya, Mariana C., et al.
Publicado: (2017) -
Call to action: overcoming enrollment disparities in cancer clinical trials with modernized eligibility criteria
por: Riner, Andrea N, et al.
Publicado: (2023) -
The association between non-English primary language and COVID-19 clinical trial eligibility and enrollment: A retrospective cohort study
por: Tait, Sarah D., et al.
Publicado: (2022)